Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-532.92%
operating margin TTM
-232.43%
revenue TTM
65.71 Million
revenue per share TTM
1.09$
valuation ratios | |
|---|---|
| pe ratio | -2.97 |
| peg ratio | -0.18 |
| price to book ratio | 12.08 |
| price to sales ratio | 8.91 |
| enterprise value multiple | -4.04 |
| price fair value | 12.08 |
profitability ratios | |
|---|---|
| gross profit margin | 87.08% |
| operating profit margin | -232.43% |
| pretax profit margin | -532.92% |
| net profit margin | -532.92% |
| return on assets | -110.21% |
| return on equity | 335.91% |
| return on capital employed | -177.56% |
liquidity ratios | |
|---|---|
| current ratio | 1.29 |
| quick ratio | 1.29 |
| cash ratio | 0.98 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -2.35 |
| cash flow to debt ratio | -749.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.15 |
| cash per share | 0.12 |
| operating cash flow per share | -0.15 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -749.00 |
| short term coverage ratios | -749.00 |
| capital expenditure coverage ratio | -327.69 |
Frequently Asked Questions
When was the last time Plus Therapeutics, Inc. (NASDAQ:PSTV) reported earnings?
Plus Therapeutics, Inc. (PSTV) published its most recent earnings results on 30-10-2025.
What is Plus Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Plus Therapeutics, Inc. (NASDAQ:PSTV)'s trailing twelve months ROE is 335.91%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Plus Therapeutics, Inc. (PSTV) currently has a ROA of -110.21%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PSTV's net profit margin stand at?
PSTV reported a profit margin of -532.92% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PSTV's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.29 in the most recent quarter. The quick ratio stood at 1.29, with a Debt/Eq ratio of 0.00.